Guerbet Stock Forecast for 2023 - 2025 - 2030
Updated on 04/28/2024
Guerbet Stock Forecast and Price Target
If the average price target of 39.05€ set by two distinguished experts for Guerbet over the past few weeks is reached this year, there would be a potential upside of approximately 4.41% from the last closing price in April, 2024. This potential increase is based on a high estimate of 42.70€ and a low estimate of 36.00€. If you're interested in GBT stock, looking at its competitors might also be a good idea.
4.41% Upside
Guerbet Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Guerbet's Price has decreased from 23.13€ to 0.00€ – a 100.00% drop. In the next year, analysts predict that Fair Value will reach 38.82€ – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ABT Stock Forecast | Abbott Laboratories | Outperform |
9
|
$107.53 | Buy/Sell | $118.92 | 17.64% |
| BSX Stock Forecast | Boston Scientific | Outperform |
11
|
$73.17 | Buy/Sell | $70.14 | 12.07% |
| MDT Stock Forecast | Medtronic | Outperform |
11
|
$79.74 | Buy/Sell | $92.47 | 19.76% |
| BDX Stock Forecast | Becton Dickinson and Co | Outperform |
9
|
$231.55 | Buy/Sell | $284.47 | 19.84% |
| EW Stock Forecast | Edwards Lifesciences Corp | Outperform |
11
|
$86.43 | Buy/Sell | $91.18 | 12.23% |
Guerbet Revenue Forecast for 2023 - 2025 - 2030
Guerbet's Revenue has grown in the last three years, jumping from 716.67€M to 795.65€M – an increase of 11.02%. In the next year, analysts predict that Revenue will reach 867.12€M – an increase of 8.98%. For the next seven years, the forecast is for Revenue to grow by 11.43%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 4543 Stock Forecast | Terumo | Outperform |
18
|
¥5.63k | Buy/Sell | ¥4.97k | -9.46% |
| TFX Stock Forecast | Teleflex Inc | Hold |
13
|
$206.71 | Buy/Sell | $263.46 | 28.20% |
| LNTH Stock Forecast | Lantheus Holdings | Buy |
14
|
$65.56 | Buy/Sell | $91.75 | 49.48% |
.jpg)
Guerbet Dividend per Share Forecast for 2023 - 2025 - 2030
In the last three years, Guerbet's Dividend per Share has decreased by 28.57%, going from 0.70€ to 0.50€. In the next year, analysts are expecting an increase in Dividend per Share, predicting it will reach 0.62€ – an increase of 24.00%. The Guerbet forecast is for Dividend per Share to reach 0.59€ or grow by 18.61%.
Guerbet EBITDA Forecast for 2023 - 2025 - 2030
Guerbet's EBITDA has decreased by 2.22% In the last three years, from 92.14€M to 90.09€M. In the next year, analysts expect EBITDA to reach 117.34€M – an increase of 30.25%. For the next seven years, the forecast is for EBITDA to grow by 48.89%.
Guerbet EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Guerbet's EBIT has decreased from 42.27€M to 39.17€M – a 7.33% drop! The next year looks promising for Guerbet, with analysts predicting EBIT of 49.53€M – an increase of 26.45%. Over the next seven years, experts anticipate that Guerbet's EBIT will grow at a rate of 151.21%.
Guerbet EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Guerbet's EPS has decreased from 1.40€ to 0.00€ – a 100.00% drop. In the next year, analysts predict that EPS will reach 2.35€ – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.
.jpg)